1Huse DM, Schulman K, Orsini L, et al. (2005) Burden of illness in Parkinson's disease. Mov Disord 20: 1449-1454.
2 The Parkinson Study Group (1989) Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 321: 13 64-1371.
3Olanow CW, Hauser RA, Gauger L, et al. (1995) The effect of deprenyl and levodopa on the progression of Parkinson's disease. Ann Neurol. 38: 771-777.
4Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, et al. (2004) The Parkinson Study Group. Levodopa and the progression of Parkinson's disease. N Engl J Med 351: 2498-2508.
5The Parkinson Study Group (2002) Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.JAMA 287: 1653-1661.
6Whone AL, Watts RL, Stoessl AJ, et al. (2003) Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study. Ann Neurol 54: 93-101.
7The Parkinson Study Group (2004) A controlled, randomized, delayed-start study of rasagiline in early Pakinson disease. Arch Neurol 61: 561-566.
8Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science. 216:136-144
9Aguzzi A, Sigurdson C, Heikenwaelder M (2008) Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 3:11-40.
10Aguzzi A (2009) Cell biology: beyond the prion principle. .Nature 459: 924-925.
11Brettschneider J, Del Tredici K, Lee VM-Y Trojanowski JQ (2015) Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16: 109-120.
12Li JY, Englund E, Holton JL, Soulet D, Hagell P, et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Med. 14:501-503.
13Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB (2008) Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 23: 2303-2306.
14Li JY, Englund E, Widner H, Rehncrona S, Björklund A, Lindvall O, et al. (2010) Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Mov Disord 25: 1091-1096.
15Chu Y, Kordower JH (2010) Lewy body pathology in fetal grafts. Ann NY Acad Sci 1184: 55-67.
16 Kurowska Z, Englund E, Widner H, Lindvall O, Li JY, et al. (2011) Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease. J. Parkinsons Dis 1: 83-92.
17Hansen C, Angot E, Bergström AL, Steiner JA, Pieri L, et al. (2011) α-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Invest 121: 715-725.
18Kordower JH, Dodiya HB, Kordower AM, Terpstra B, Paumier K, et al. (2011) Transfer of host-derived α synuclein to grafted dopaminergic neurons in rat. Neurobiol Dis 43: 552-557.
19Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, et al. (2011) Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72: 57-71.
20Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E et al. (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A. 106: 13010-13015.
21Mougenot AL, Nicot S, Bencsik A, Morignat E, et al. (2012) Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging 33: 2225-2228.
22Luk KC, Kehm VM, Zhang B, O'Brien P, et al. (2012) Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J. Exp Med 209: 975-986.
23Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, et al. (2013) Prion-like spreading of pathological α-synuclein in brain. Brain 136: 1128-1138.
24Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, et al. (2012) Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338: 949-953.
25Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM et al. (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci USA 110: 19555-19560.
26Recasens A, Dehay B, Bové J, Carballo-Carbajal I, Dovero S, et al. (2014) Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol 75: 351-362.
27Angot E, Steiner JA, Lema Tomé CM, Ekström P, Mattsson B, et al. (2012) Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo. PLoS One 7: e39465.
28Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell.J. Biol Chem 284: 12845-12852.
29Munch C, O'Brien J, Bertolotti A (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells.Proc. Natl Acad. Sci. USA 108: 3548-3553.
30Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, et al. (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci USA 110: E3138-E3147.
31Wu JW, Herman M, Liu L, Simoes S, Acker CM, et al. (2013) Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons.J Biol Chem 288: 1856-1870.
32Lee HJ, Suk JE, Bae EJ, Lee JH, Paik SR, et al. (2008) Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int. J Biochem Cell Biol 40: 1835-1849.
33Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, et al (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice.Proc Natl Acad Sci USA 106: 20057-20062.
34Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, et al. (2003) Staging of brain pathology related to sporadic Parkinson's disease.Neurobiol Aging 24: 197-211.
35Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain ? J. Neuropathol. Exp. Neurol 61: 413-426.
36Del Tredici K, Braak H (2012) Spinal cord lesions in sporadic Parkinson's disease.Acta Neuropathol 124: 643-664.
37Braak H, Del Tredici K. (2009) Neuroanatomy and pathology of sporadic Parkinson's disease.Adv Anat Embryol Cell Biol 201: 1-119.
38van de Berg WD, Hepp DH, Dijkstra AA, Rozemuller JA, Berendse HW et al. (2012) Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease.Parkinsonism Relat Disord 18: S28-S30.
39Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100 years of Lewy pathology. Nature Rev Neurol 9: 13-24.
40Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson's disease.Mov Disord 10: 283-287.
41Hawkes CH, Shephard BC, Daniel SE (1999) Is Parkinson's disease a primary olfactory disorder? QJM 92: 473-480.
42Aiello GL, Bach-y-Rita P (2000) The cost of an action potential.J Neurosci Methods 103: 145-149.
43Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, et al. (2000) Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions.Science 290: 985-989.
44Chung CY, Khurana V, Auluck PK, Tardiff DF, Mazzulli JR, et al. (2013) Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons.Science 342: 983-987.
45Ryan SD, Dolatabadi N, Chan SF, Zhang X, Akhtar MW, et al. (2013) Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription.Cell 155: 1351-1364.
46Zuo L, Motherwell MS (2013) The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.Gene 532: 18-23.
47Dolei A, Uleri E, Ibba G, Caocci M, Piu C, et al. (2015) The aliens inside human DNA: HERV-W/MSRV/syncytin-1 endogenous retroviruses and neurodegeneration.J Infect Dev Ctries 9: 577-587.
48Denner J. Endogenous Retroviruses. In Retroviruses: Kurth R, Bannert N. Hethersett (eds) Molecular Biology, Genomics and Pathogenesis. Norwich, UK: Caister Academic Press.
49Stengel A, Bach C, Vorberg I, Frank O, Gilch S, et al. (2006) Prion infection influences murine endogenous retrovirus expression in neuronal cells.Biochemical and biophysical research communications 343: 825-831.
50Jeong BH, Lee YJ, Carp RI, Kim YS (2010) The prevalence of human endogenous retroviruses in cerebrospinal fluids from patients with sporadic Creutzfeldt-Jakob disease.J Clin Virol 47: 136-142.
51Greenwood AD, Vincendeau M, Schmädicke AC, Montag J, Seifarth W, Motzkus D. (2011) Bovine spongiform encephalopathy infection alters endogenous retrovirus expression in distinct brain regions of cynomolgus macaques (Macaca fascicularis).Molecular Neurodegeneration 6: 44.
52de Font-Réaulx E, Dorazco-Barragán G (2010) [Clinical stabilisation in neurodegenerative diseases: clinical study in phase II]. Rev Neurol 50: 520-528.
53Graf E. (1992) Antioxidant potential of ferulic acid.Free Radical Biology and Medicine 13: 435-448.
54Trombino S, Serini S, Di Nicuolo F, Celleno L, et.al. (2004) Antioxidant effect of ferulic acid in isolated membranes and intact cells: synergistic interactions with alpha-tocopherol, beta-carotene, and ascorbic acid. J Agric Food Chem 52: 2411-2420.
55Kuenzig W, Chau J, Norkus E, Holowaschenko H, Newmark H, (1984) Caffeic and ferulic acid as blockers of nitrosamine formation.Carcinogenesis 5: 309-313.
56Ogiwara T, Satoh K; Negoro T; Okayasu H; Sakagami H; Fujisawa S (2003) Inhibition of NO production by activated macrophages by phenol-carboxylic acid monomers and polymers with radical scavenging activity.Anticancer Res. 23: 1371-1323.
57Antony JM, van Marle G, Opii W, Butterfield DA, Mallet F, Wee Yong V, et al. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nature Neuroscience 7: 1088-1095.
58Kudo Y, Boyd CA, Sargent IL, Redman CW (2003) Hypoxia alters expression and function of syncytin and its receptor during trophoblast cell fusion of human placental BeWo cells: implications for impaired trophoblast syncytialisation in pre-eclampsia. Biochim Biophys Acta 1638: 63-71.
59Mi S, Lee X, Li X, Veldeman GM, Finnerty H, et al.(2000) Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403: 785-789.
60Mattson MP, Taub DD (2004) Ancient viral protein enrages astrocytes in multiple sclerosis. Nat Neurosci 7: 1021-123.
61Sohn YT, Oh JH (2003) Characterization of physicochemical properties of ferulic acid. Arch Pharm Res 26: 1002-1008.
62Zhaohui Zhang, Taotao Wei, Jingwu Hou, Gengshan Li, Shaozu Yu, Wenjuan Xin (2003) Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. European Journal of Pharmacology 467: 41-47.
63Sakai S. Ochiai H.; Nakajima K. Terasawa K (1997) Inhibitory effect of ferulic acid on macrophague inflammatory protein-2 production in a murine macrophague cell line, RAW264.7. Cytokine 9: 242-248.
64Ogiwara T, Satoh K, Kadoma Y, et al. Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res 22: 2711-2717.
65Hirata A, Murakami Y, Atsumi T, Shoji M, et al. (2005) Ferulic acid dimer inhibits lipopolysaccharide-stimulated cyclooxygenase-2 expression in macrophages. In Vivo 19: 849-53.
66Ogiwara T, Satoh K, Negoro T, Okayasu H, Sakagami H, Fujisawa S (2003) Inhibition of NO production by activated macrophages by phenolcarboxylic acid monomers and polymers with radical scavenging activity. Anticancer Res 23: 1317-1323.
67Ogiwara T, Satoh K, Kadoma Y, Murakami Y, Unten S, et al. (2002) Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res 22: 2711-2717.
68Elsisi NS, Darling-Reed S, Lee EY, Oriaku ET, Soliman KF (2005) Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia. Neurosci Lett 375: 91-96.
69Hougee S, Sanders A, Faber J, Graus YM, et al. (2005) Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem Pharmacol 15; 69: 241-248.
70Hirano T. (2004) Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. Int Arch Allergy Immunol 134:135-140.
71Liang YC, Huang YT, Tsai SH, et al (1999) Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20: 1945-1952.
72Reddy KB, Krueger JS, Kondapaka SB (1999) Mitogen activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP9) in breast epithelial cells. Int J Cancer 82: 268-273.
73Nielsen SE, Young JF, Daneshvar B, et al. (1999) Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br J Nutr Jun 81: 447-455.
74Asghar Z, Masood Z (2008) Evaluation of antioxidant properties of silymarin and its potential to inhibit peroxyl radicals in vitro. Pak J Pharm Sci. 21: 249-254.
75Hiramatsu K, Tani T, Kimura Y, Izumi S, Nakane PK (1990) Effect of gamma-oryzanol on atheroma formation in hypercholesterolemic rabbits. Tokai J Exp Clin Med 15: 299-305.
76Fahn S and the Parkinson Study Group (2005) Does levodopa slow or hasten the rate of progression of Parkinson's disease? Journal of Neurology Suppl 4:IV37-IV42.